Global Surgical Site Infection Prevention and Control Devices Market Growth 2023-2029

Global Surgical Site Infection Prevention and Control Devices Market Growth 2023-2029

SSIs are potential complications associated with any type of surgical procedure. Although SSIs are among the most preventable HAIs, they still represent a significant burden in terms of patient morbidity and mortality and additional costs to health systems and service payers worldwide. SSI is both the most frequently studied and the leading HAI reported hospital-wide in LMICs. For these reasons, the prevention of SSI has received considerable attention from surgeons and infection control professionals, health care authorities, the media and the public. In particular, there is a perception among the public that SSIs may reflect a poor quality of care.

Many factors influence surgical wound healing and determine the potential for infection. These include patient-related (endogenous) and process/procedural-related (exogenous) variables that affect a patient’s risk of developing an SSI. Some variables are obviously not modifiable, such as age and gender. However, other potential factors can be improved to increase the likelihood of a positive surgical outcome, such as nutritional status, tobacco use, correct use of antibiotics and the intraoperative technique.

LPI (LP Information)' newest research report, the “Surgical Site Infection Prevention and Control Devices Industry Forecast” looks at past sales and reviews total world Surgical Site Infection Prevention and Control Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Surgical Site Infection Prevention and Control Devices sales for 2023 through 2029. With Surgical Site Infection Prevention and Control Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surgical Site Infection Prevention and Control Devices industry.

This Insight Report provides a comprehensive analysis of the global Surgical Site Infection Prevention and Control Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Surgical Site Infection Prevention and Control Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Surgical Site Infection Prevention and Control Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surgical Site Infection Prevention and Control Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surgical Site Infection Prevention and Control Devices.

The global Surgical Site Infection Prevention and Control Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In ASEAN market, key players of surgical site infection prevention and control devices include 3M Company, Cardinal Health, Inc., B. Braun Melsungen AG and ME Medical, etc.

In terms of type, skin preparation is most popular and has a market share of about 60%, followed by hair removal devices and wound rinse. In terms of application, oncology is the dominant field using surgical site infection prevention and control devices. Other application include orthopaedic, general surgery and paediatric surgery.

This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Site Infection Prevention and Control Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Hair Removal Devices
Skin Preparation
Wound Rinse

Segmentation by application
Oncology
Orthopaedic
General Surgery
Paediatric Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M Company
Cardinal Health, Inc.
B. Braun Melsungen AG
ME Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Surgical Site Infection Prevention and Control Devices market?

What factors are driving Surgical Site Infection Prevention and Control Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Surgical Site Infection Prevention and Control Devices market opportunities vary by end market size?

How does Surgical Site Infection Prevention and Control Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.